Description
As part of a combined antiviral therapy regimen, sofosbuvir, an HCV nucleotide analog NSSB polymerase inhibitor, is recommended for the treatment of chronic HCV infection.
₨4,500.00
As part of a combined antiviral therapy regimen, sofosbuvir, an HCV nucleotide analog NSSB polymerase inhibitor, is recommended for the treatment of chronic HCV infection.




Reviews
There are no reviews yet.